2023-11-14T15:51:46+00:00 2022-12-31 350921680 CROWE LLP 225 West Wacker Drive Suite 2600 Chicago IL 606061224 990 2022-01-01 462882271 Indiana Biosciences Research Institute Inc INDI 3179833350 1210 Waterway Blvd 2000 Indianapolis IN 46202 Alan Palkowitz President & CEO 2023-11-14 true Michele Sawyer 999009999 Jennifer Burke P01342224 3128997000 2022 2023-04-26 12:10:37Z Alan Palkowitz 1210 Waterway Blvd 2000 Indianapolis IN 46202 69348963 false X www.indianabiosciences.org X 2013 IN THE IBRI IS AN INDEPENDENT LIFE SCIENCES RESEARCH INSTITUTE FOCUSED ON ADDRESSING MAJOR UNDERSERVED AREAS OF PUBLIC HEALTH INCLUDING DIABETES, PEDIATRIC RARE DISEASES, AND ALZHEIMER'S DISEASE. THE IBRI FACILITATES THE GROWTH OF THE BIOMEDICAL COMMUNITY BY ATTRACTING TALENT AND INDUSTRY TO THE STATE AND AIDES IN THE COMMERCIALIZATION OF TECHNOLOGIES TO FOSTER FURTHER ECONOMIC DEVELOPMENT. 17 9 46 18 -23020 0 905773 1140289 1351832 1195106 7753531 1764523 -2214 -1610 10008922 4098308 0 0 4744087 4777296 500 24843 807081 8937013 8072531 13681600 12874670 -3672678 -8776362 179409136 149263304 30934744 29016876 148474392 120246428 TO BECOME A LEADING INDEPENDENT RESEARCH INSTITUTE IN THE DISCOVERY AND DEVELOPMENT OF INNOVATIVE SOLUTIONS TO IMPROVE HUMAN HEALTH. false false 10131381 1195106 FOUNDED IN 2013, THE INDIANA BIOSCIENCES RESEARCH INSTITUTE'S (IBRI) SCIENTIFIC RESEARCH FOCUSES ON DISCOVERING INNOVATIVE SOLUTIONS FOR UNDERSERVED DISEASES, INCLUDING DIABETES, PEDIATRIC RARE DISEASES AND ALZHEIMER'S DISEASE. SEE THE FULL IBRI 2022 ANNUAL REPORT AT HTTPS://WWW.INDIANABIOSCIENCES.ORG/ANNUALREPORT2022 FOR PROGRAM SERVICE ACCOMPLISHMENTS. 10131381 true true false false false false false false true true true false true true true true false false true true false false true false false false false false true false false false false false false false false false false false false false true true false false false true 28 0 true 46 true false false false false false false false false false false false false X 17 9 false false false false false true false true true false false true true true true true true true true true true IN X Michele Sawyer 3179833350 1210 Waterway Blvd INDIANAPOLIS IN 46202 ALAN PALKOWITZ PhD PRESIDENT & CEO 32.0 8.0 X X 418375 92338 48349 DANIEL F EVANS JR EXECUTIVE CHAIR 0.5 X X 0 0 0 WAYNE BURRIS TREASURER (until 12/1/22) 0.5 X X 0 0 0 AARON SCHACHT DIRECTOR 0.5 X 0 0 0 CRISTOPHER JOHNSTON DIRECTOR 0.5 39.5 X 0 155020 46338 DANIEL GOLDEN DIRECTOR 0.5 X 0 0 0 DANIEL PETERSON DIRECTOR 0.5 X 0 0 0 DAVID INGRAM MD DIRECTOR 0.5 X 0 0 0 HANY MOSELHI MD DIRECTOR 0.5 X 0 0 0 JAY HESS MD PhD MHSA, DIRECTOR 0.5 39.5 X 0 1007750 335652 JOHN C LECHLEITER PhD DIRECTOR 0.5 X 0 0 0 KENNETH CUSTER PhD DIRECTOR 0.5 X 0 0 0 MICHAEL HUBER VP FOR UNIVERSITY RELATIONS (PARTIAL YEAR) 0.5 39.5 X 0 57288 0 PATRICIA MARTIN DIRECTOR 0.5 39.5 X 0 439855 73286 ROBERT BERNHARD PhD DIRECTOR 0.5 39.5 X 0 495891 0 TATIANA FOROUD PhD DIRECTOR 0.5 39.5 X 0 553341 48749 THERESA MAYER PhD DIRECTOR 0.5 39.5 X 0 400716 69101 WENDY SRNIC PhD DIRECTOR 0.5 X 0 0 0 WILLIAM B STEPHAN DIRECTOR (until 10/31/22) 0.5 39.5 X 0 394134 50127 JOHN (JAY) M MCGILL PhD CHIEF OPERATING OFFICER 39.5 0.5 X 322881 0 31498 MARK ANDERSEN CHIEF FINANCIAL OFFICER (PARTIAL YEAR) 40.0 X 136013 0 15622 MICHELE J SAWYER CHIEF FINANCIAL OFFICER (PARTIAL YEAR) 40.0 X 124953 0 5827 BRIAN FILLENWARTH FINANCIAL CONTROLLER 40.0 X 173750 0 11992 DANIEL ROBERTSON PhD RESEARCH FELLOW & VP OF DIGITAL TECHNOLOGY (PARTIAL YEAR) 40.0 X 134970 0 16854 JOSINE M VAN KLEY VP OF DEVELOPMENT AND ADVANCEMENT 40.0 X 222936 0 25071 MARY M MADER VP MOLECULAR INNOVATION (PARTIAL YEAR) 40.0 X 219327 0 24842 MUSTAPHA MOUSSAIF PhD SR STAFF SCIENTIST 40.0 X 126192 0 26130 1879397 3596333 829438 15 false true false BROWNING INVESTMENTS LLC 8940 River Crossing Blvd Suite 300 Indianapolis IN 46240 Tenant Improvements 1660234 Strategic Investment Group 1001 Nineteenth Street North 16th Floor Arlington VA 22209 Investment Services 488733 HD BIOSCIENCES INC Unit 826 8/F Ocean CTR 5 Canton Rd TST Harbour City KLN HK Research Services 289405 BlackInk IT 1101 E 16th Street Suite 300 Indianapolis IN 46202 IT Support 196072 3 775622 364667 1140289 Research Collaboration 541700 1183642 1183642 Research Services 541700 11464 11464 0 0 0 0 1195106 2212257 -23020 2235277 407292 408902 -1610 0 -1610 -1610 64394019 64841753 -447734 0 -447734 -447734 0 0 0 0 0 0 0 4098308 1195106 -23020 1785933 1076509 518530 126038 431941 3220451 2447543 708499 64409 145608 110662 33490 1456 211981 148387 44516 19078 122747 92060 27004 3683 44761 24660 4932 15169 48667 0 48667 0 24843 24843 550218 412663 82533 55022 514910 397139 110780 6991 189025 131748 15627 41650 46709 35032 7941 3736 363508 293433 46345 23730 2132091 1620914 468674 42503 135758 113429 11404 10925 18587 15541 1781 1265 313706 184287 95887 33532 1736036 1631874 86802 17360 96429 74895 13356 8178 Lab Expenses 1866024 1866024 0 0 Other Expenses 16102 12560 1932 1610 0 0 0 0 12874670 10131381 1936208 807081 1613809 2425366 5932435 0 236205 702021 0 0 0 0 111646 212987 18002943 6706637 9888401 11296306 42429316 17596618 99776488 98156150 0 19420836 18873856 179409136 149263304 1276693 1991666 0 0 1476436 915189 0 0 0 0 0 0 8256475 7286454 19925140 18823567 30934744 29016876 X 93570142 74986763 54904250 45259665 148474392 120246428 179409136 149263304 X -8776362 -16127975 -3323627 X false true X true false X X X 5 CENTRAL INDIANA CORPORATE PARTNERSHIP INC 352065459 9 true 2000 0 STATE OF INDIANA 000000000 6 true 0 0 INDIANA UNIVERSITY 356001673 2 true 679346 0 PURDUE UNIVERSITY 356002041 2 true 0 0 UNIVERSITY OF NOTRE DAME DU LAC 350868188 2 true 50000 0 5 731346 0 true true true true true false false false false false false false false false false false false true false Schedule A, Part IV, Section A, Line 3b Section A, Line 3b For the supported organization qualified under section 501(c)(6), Central Indiana Corporate Partnership, we reviewed the most recent Form 990 filed for the organization to determine the organization satisfied the public support test requirements. Schedule A, Part IV, Section A, Line 3c Section A, Line 3C Our purchasing and cash disbursements policies ensure that support provided by IBRI to supported organizations is used exclusively for section 170(c)(2)(B) purposes. Schedule A, Part IV, Section A, Line 2 Supported Org. Without IRS Status 509(a)1 or (2) Of IBRI's supported organizations, Indiana University, Purdue University, and the State of Indiana do not have determination letters from the Internal Revenue Service ("IRS") confirming their exempt status under section 509(a)(1) or (2). Indiana University and Purdue University are both state universities and thus are not required to obtain recognition of their tax-exempt status. The State of Indiana is a governmental unit described in section 170(b)(1)(A)(v) and is not required to obtain recognition of its tax-exempt status. Schedule A, Part IV, Section A, Line 3b Qualified Under 501C(4)(5) Or (6) Central Indiana Corporate Partnership, Inc. ("CICP") is recognized by the IRS as a tax-exempt business league described in section 501(c)(6). IBRI requested and received confirmation from CICP that it would satisfy the public support test under section 509(a)(2). CICP annually analyzes its financial records to assess whether it would satisfy the public support test under section 509(a)(2). Schedule A, Part IV, Section A, Line 3c Support To Org. Used Exclusively Sec. 170(c)(2)(B) Purposes IBRI ensures that all support to CICP is used exclusively for section 170(c)(2)(B) purposes by reminding CICP of such limitation on the support that IBRI provides to CICP and by regularly confirming with CICP that any and all support IBRI provides to CICP was used exclusively for charitable and exempt purposes described in section 170(c)(2)(B). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 142205804 1495845 -14435912 13512967 115752770 141951538 745787 7184390 7675911 142205804 128938033 15523690 11889815 14400000 141951538 111610169 16576898 10750966 7700000 2300000 128938033 107715560 5000000 -1105391 111610169 0.6176 0.3772 0.0052 false false 8900369 1023558 7876811 8902589 5543683 3358906 199985 139396 60589 11296306 Commingled Investment Funds 98156150 F 98156150 Lease Right of Use Asset 18147249 Interest Rate Swap 726607 18873856 Bldg lease liability 18823567 18823567 X -16149205 -16127975 -3569320 -19697295 3548090 550218 0 550218 4098308 12733354 0 0 12733354 550218 -408902 141316 12874670 Schedule D, Part V, Line 4 Intended uses of endowment funds THE ENDOWMENT FUNDS ARE INTENDED TO SUPPORT THE ONGOING OPERATIONS OF THE IBRI. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Institute is exempt from income taxes under §501(c)(3) of the U.S. Internal Revenue Code and is classified as a public charity under §509(a)(1) and §170(b)(1)(A)(vi). The Institute has adopted accounting guidance related to accounting for uncertainty in income taxes. This guidance requires the Institute to recognize a tax benefit only if it is more likely than not the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50 percent likely of being realized on examination. For tax positions not meeting the more-likely-than-not test, no tax benefit is recorded. The Institute has examined this issue and has determined there are no material contingent liabilities or questionable tax positions. The Institute does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Institute recognizes interest and/or penalties related to income tax matters in income tax expense. The Institute did not have any amount accrued for interest and penalties at December 31, 2022 or 2021. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 Rental Expense - 408902 Write off of receivable - -3978222 Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements Rental Expense - -408902 East Asia and the Pacific 0 1 Program Services SCIENTIFIC ADVISORY SERVICES 289405 Central America and the Caribbean 0 0 Investments n/a 26843908 North America (Canada & Mexico only) 0 1 Program Services IT Services 893 0 2 0 0 0 2 27134206 0 27134206 true false true true false false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements CENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual X X X true GONSER GERBER 1776 Legacy Circle Suite 100 NAPERVILLE IL 60563 CONSULTING false 24843 -24843 0 24843 -24843 CA CO CT FL GA AL HI IL KS KY ME AK MD MA MI MN MS MO NV NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA AR WA WV WI X X X X X false false false false false false false false false ALAN PALKOWITZ PhD PRESIDENT & CEO 418298 42338 0 0 77 50000 19170 5179 2170 21830 439715 119347 0 14627 WILLIAM B STEPHAN DIRECTOR (until 10/31/22) 0 277620 0 0 0 116514 0 30500 0 19627 0 444261 0 69584 PATRICIA MARTIN DIRECTOR 0 374117 0 63100 0 2638 0 7800 0 65486 0 513141 0 0 ROBERT BERNHARD PhD DIRECTOR 0 495891 0 0 0 0 0 0 0 0 0 495891 0 0 TATIANA FOROUD PhD DIRECTOR 0 262163 0 88678 0 202500 0 38527 0 10222 0 602090 0 26790 JAY HESS MD PhD MHSA, DIRECTOR 0 584665 0 203598 0 219487 0 310225 0 25427 0 1343402 0 20549 CRISTOPHER JOHNSTON DIRECTOR 0 155020 0 0 0 0 0 23091 0 23247 0 201358 0 0 THERESA MAYER PhD DIRECTOR 0 336754 0 60000 0 3962 0 30500 0 38601 0 469817 0 0 MARK ANDERSEN CHIEF FINANCIAL OFFICER (PARTIAL YEAR) 135831 0 164 0 18 0 8406 0 7216 0 151635 0 0 0 JOHN (JAY) M MCGILL PhD CHIEF OPERATING OFFICER 322691 0 113 0 77 0 19069 0 12429 0 354379 0 0 0 BRIAN FILLENWARTH FINANCIAL CONTROLLER 173707 0 2 0 41 0 10427 0 1565 0 185742 0 0 0 MUSTAPHA MOUSSAIF PhD SR STAFF SCIENTIST 124232 0 1883 0 77 0 7744 0 18386 0 152322 0 0 0 DANIEL ROBERTSON PhD RESEARCH FELLOW & VP OF DIGITAL TECHNOLOGY (PARTIAL YEAR) 134792 0 138 0 40 0 8437 0 8417 0 151824 0 0 0 JOSINE M VAN KLEY VP OF DEVELOPMENT AND ADVANCEMENT 222788 0 107 0 41 0 13932 0 11139 0 248007 0 0 0 MARY M MADER VP MOLECULAR INNOVATION (PARTIAL YEAR) 204262 0 15000 0 65 0 12500 0 12342 0 244169 0 0 0 Form 990, Part VI, Line 1a Delegate broad authority to a committee THE BOARD OF DIRECTORS DELEGATES BROAD AUTHORITY TO AN EXECUTIVE COMMITTEE TO ACT ON THE ORGANIZATION'S BEHALF. THE COMMITTEE IS ESTABLISHED BY THE BOARD TO EXERCISE THE POWERS OF THE BOARD IN RELATED TO MATTERS THAT ARISE BETWEEN REGULARLY SCHEDULED BOARD MEETINGS AND/OR WHEN IT IS NOT PRACTICAL OR FEASIBLE FOR THE BOARD TO MEET. THE COMMITTEE IS COMPRISED OF TWO (2) OR MORE DIRECTORS OF THE CORPORATION. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body SUPPORTED ORGANIZATIONS HAVE THE RIGHT TO APPOINT DIRECTORS AS SPECIFIED IN INDIANA BIOSCIENECS RESEARCH INSTITUTE'S AMENDED AND RESTATED BYLAWS. Form 990, Part VI, Line 11b Review of form 990 by governing body IBRI'S FORM 990 WAS PREPARED BY THE FINANCE DEPARTMENT AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM AND BY THE IBRI'S LEGAL COUNSEL. SUBSEQUENTLY, A SUBSTANTIALLY COMPLETE FORM 990 AND SUPPLEMENTAL SCHEDULES WERE PRESENTED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. Form 990, Part VI, Line 12c Conflict of interest policy It is the policy of IBRI and its Board of Directors that the Corporation's directors, officers, and employees carry out their respective duties in a fashion that avoids actual, potential, or perceived conflicts of interest. IBRI's directors, officers, and employees shall have the continuing, affirmative duty to report any personal ownership, interest, or other relationship that might affect their ability to exercise impartial, ethical, and business-based judgments in fulfilling their responsibilities to the organization. Each year directors, officers, and employees acknowledge and agree that they have a duty to avoid business, financial or other interests or relationships that conflict with the interests of the Institute or that divide their loyalty to the Institute. Any activity that appears to present a conflict must be disclosed to the Institute and must be avoided or terminated unless the Institute in its sole discretion determines the activity is not harmful to the Institute or otherwise improper. The Board of Directors shall be responsible for oversight of all disclosures or failures to disclose and for taking appropriate action in the case of any actual or potential conflict of interest transaction. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE BOARD OF DIRECTORS DETERMINES COMPENSATION FOR THE CEO USING COMPARABILITY DATA AND COMPENSATION SURVEYS. A COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS CONTEMPORANEOUSLY DOCUMENTS THE DELIBERATION AND DECISION OF THIS PROCESS. THIS PROCESS OCCURS ANNUALLY AND LAST OCCURRED IN AUGUST 2022. Form 990, Part VI, Line 15b Process to establish compensation of other employees A COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS DETERMINES COMPENSATION FOR THE COO AND CFO USING COMPARABILITY DATA AND COMPENSATION SURVEYS. THE BOARD CONTEMPORANEOUSLY DOCUMENTS THE DELIBERATION AND DECISION OF THIS PROCESS. THIS PROCESS OCCURS ANNUALLY AND LAST OCCURRED IN AUGUST 2022. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON WRITTEN REQUEST. Form 990, Part XI, Line 9 Other changes in net assets or fund balances Change in fair value of interest rate swap - 654595; Write off of receivable - -3978222; FORM 990, PART VII, LINE 1A BOARD MEMBER COMPENSATION Compensation reported in Part VII and Schedule J for Board Members who are employees of Indiana University, Purdue University, Central Indiana Corporate Partnership Inc, and University of Notre Dame, Du Lac is compensation annually reported and disclosed as required under state statute. In addition, some of these individuals participate in retirement and benefit plans provided by the supported organizations. FORM 990, SCHEDULE J, PART II BOARD MEMBER COMPENSATION Compensation reported in Part VII and Schedule J for Board Members who are employees of Indiana University, Purdue University, Central Indiana Corporate Partnership Inc, and University of Notre Dame, Du Lac is compensation annually reported and disclosed as required under state statute. In addition, some of these individuals participate in retirement and benefit plans provided by the supported organizations. 16 TECH COMMUNITY CORPORATION 300 NORTH MERIDIAN STREET SUITE 950 INDIANAPOLIS IN 46204 810853467 FOSTER ECONOMIC DEVELOPMENT IN THE CITY OF INDIANAPOLIS IN 501(c)(3) Type I NA false STATE OF INDIANA 1 North Capitol Ave Suite 700 Indianapolis IN 46204 Indiana State government IN 501(c)(1) na false CENTRAL INDIANA CORPORATE PARTNERSHIP INC 1210 Waterway Blvd Ste 5000 Indianapolis IN 46202 352065459 Economic development IN 501(c)(6) na false INDIANA UNIVERSITY 400 E 7th St Rm 501 Bloomington IN 47405 356001673 Education IN 501(c)(3) 2 NA false PURDUE UNIVERSITY 1281 Win Hentschel Blvd Suite 1100 West Lafayette IN 47906 356002041 Education IN 501(c)(3) 2 na false UNIVERSITY OF NOTRE DAME DU LAC Controllers Office 724 Grace Hall Notre Dame IN 46556 350868188 Education IN 501(c)(3) 2 na false false false true false false false false true false false false true true false true false false false false